Yuyu Pharma, Inc. (KRX:000220)

Yuyu Pharma Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	143,520	140,885	133,147	137,210	138,881	115,655
Revenue Growth	8.20%	5.81%	-2.96%	-1.20%	20.08%	17.87%
Gross Profit Gross Profit Growth	54,438	53,586	51,369	48,527	52,966	45,088
Operating Income Operating Income Growth	11,405	11,019	12,582	-748.94	-592.11	1,200
Net Income Net Income Growth	8,647	7,830	8,720	-6,303	-6,273	-2,499
Earnings Per Share EPS Growth	536.27	481.00	513.00	-387.43	-378.31	-157.00
EPS Growth	43.58%	-6.24%	-	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	29,887	32,705	42,650	32,354	30,778	50,263
Total Debt Total Debt Growth	26,214	27,923	33,644	39,407	39,276	39,166
Net Cash (Debt) Net Cash Growth	3,672	4,783	9,005	-7,053	-8,499	11,097
Net Cash Growth	-67.96%	-46.89%	-	-	-	1907.08%
Net Cash Per Share Net Cash Per Share Growth	179.20	237.87	529.76	-433.55	-512.57	695.34

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	15,023	15,877	24,950	420.86	-6,229	4,509
Capital Expenditures CapEx Growth	-10,625	-8,253	-7,112	-4,514	-5,283	-6,073
Free Cash Flow Free Cash Flow Growth	4,398	7,625	17,838	-4,094	-11,512	-1,565
Free Cash Flow Growth	-78.81%	-57.26%	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	37.93%	38.04%	38.58%	35.37%	38.14%	38.98%
Operating Margin	7.95%	7.82%	9.45%	-0.55%	-0.43%	1.04%
Pretax Margin	6.97%	6.73%	7.50%	-3.97%	-2.74%	-0.33%
Profit Margin	6.02%	5.56%	6.55%	-4.59%	-4.52%	-2.16%
FCF Margin	3.06%	5.41%	13.40%	-2.98%	-8.29%	-1.35%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	7.15	9.08	8.36	-	-	-
Forward PE	-	21.92	21.92	21.92	21.92	21.92
P/FCF Ratio	13.73	9.32	4.09	-	-	-
PS Ratio	0.42	0.51	0.55	0.62	0.74	1.13

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 12, 2026

Data Sources Report a data error